Pivotal Bioventure Partners Investment Advisor LLC
Investment Portfolio & 13F Holdings Analysis
About
Pivotal bioVenture Partners Investment Advisor LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 11 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.
AI_NATIVE detailed information: This accession holds the following tickers:[ "ARQT", "RXRX", "BIOA", "BOLT", null, "RLYB", "ZBIO", "IOBT", "INZY", "VIGL", "PCVX" ]
Filing Details
13F-HR • 2025-03-31
Filing Details
13F-HR • 2025-03-31- Report Date
- 2025-03-31
- Filing Date
- 2025-05-14
- Total Holdings
- 11
- Total Value
- 123562016
- Accession Number
- 0001012975-25-000233
- Form Type
- 13F-HR
- Manager Name
- Pivotal-Bioventure-Partners-Investment-Advisor
Data Enrichment
91% identified10 identified1 unidentified
Holdings
11 positions • $123.6M total value
Manager:
Search and click to pin securities to the top
H5870P102
Shares:2.3M
Value:$43.8M
% of Portfolio:35.4% ($43.8M/$123.6M)
Shares:2.1M
Value:$33.2M
% of Portfolio:26.8% ($33.2M/$123.6M)
Shares:595.5K
Value:$3.2M
% of Portfolio:2.5% ($3.2M/$123.6M)
Shares:560.6K
Value:$997.9K
% of Portfolio:0.8% ($997.9K/$123.6M)
Instrument | Shares | Other Manager | Value | % of Portfolio | ||
---|---|---|---|---|---|---|
(cusipH5870P102)✕ | 2.3M | All Managers (Combined) | $43.8M | 35.4% ($43.8M/$123.6M) | ||
2.1M | QoQ 0.00% (+0) | All Managers (Combined) | $33.2M | 26.8% ($33.2M/$123.6M) | ||
Vaxcyte, Inc.(PCVXcusip92243G108) | 710.7K | All Managers (Combined) | $26.8M | 21.7% ($26.8M/$123.6M) | ||
736.6K | QoQ 0.00% (-0)YoY NEW(+736.6K) | All Managers (Combined) | $5.8M | 4.7% ($5.8M/$123.6M) | YoY NEW(+$5.8M) | |
4.5M | All Managers (Combined) | $4.1M | 3.3% ($4.1M/$123.6M) | |||
595.5K | QoQ 0.00% (-0)YoY NEW(+595.5K) | All Managers (Combined) | $3.2M | 2.5% ($3.2M/$123.6M) | YoY NEW(+$3.2M) | |
653.4K | QoQ 0.00% (-0)YoY NEW(+653.4K) | All Managers (Combined) | $2.5M | 2.0% ($2.5M/$123.6M) | YoY NEW(+$2.5M) | |
Rallybio Corp(RLYBcusip75120L100) | 2.4M | All Managers (Combined) | $1.6M | 1.3% ($1.6M/$123.6M) | ||
560.6K | All Managers (Combined) | $997.9K | 0.8% ($997.9K/$123.6M) | |||
864.2K | All Managers (Combined) | $942.0K | 0.8% ($942.0K/$123.6M) | |||
1.9M | All Managers (Combined) | $756.6K | 0.6% ($756.6K/$123.6M) |